05 October 2010

Mylan gets FDA approval for generic Reyataz

Mylan Inc. said Tuesday that it received tentative Food and Drug Administration approval for a generic version of Bristol-Myers Squibb Co.'s HIV drug Reyataz.

Mylan received approval under the President's Emergency Plan for AIDS Relief. The generic drug will be eligible for sales outside the U.S.

Reyataz, or atazanavir sulfate capsules, are used in combination with other medications to control HIV infection.

**Published by "AP"

No comments:

Post a Comment

CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies

Copyright © Noticia de Salud